Nektar Therapeutics (NKTR) — Cash Flow-to-Debt Ratio
Nektar Therapeutics (NKTR) has a Cash Flow-to-Debt Ratio of -0.24x as of March 2026, meaning its operating cash flow of $-44.30 Million could theoretically repay 0% of its total liabilities ($187.06 Million) in one year. Explore Nektar Therapeutics (NKTR) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Nektar Therapeutics Cash Flow-to-Debt Ratio (1994–2025)
Historical debt coverage capacity for Nektar Therapeutics across 32 annual periods. Also explore how large is Nektar Therapeutics's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Nektar Therapeutics (1994–2025)
Year-by-year debt coverage analysis for Nektar Therapeutics. For market capitalisation and broader financial context, see Nektar Therapeutics (NKTR) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.09x | $-208.51 Million | $190.57 Million | ▼ -51.4% |
| 2024 | -0.72x | $-175.71 Million | $243.11 Million | ▼ -0.2% |
| 2023 | -0.72x | $-192.61 Million | $267.05 Million | ▲ +18.4% |
| 2022 | -0.88x | $-304.01 Million | $343.96 Million | ▲ +6.3% |
| 2021 | -0.94x | $-412.66 Million | $437.68 Million | ▼ -38.9% |
| 2020 | -0.68x | $-313.29 Million | $461.47 Million | ▼ -18.1% |
| 2019 | -0.57x | $-328.68 Million | $571.97 Million | ▼ -134.6% |
| 2018 | 1.66x | $718.21 Million | $432.60 Million | ▲ +969.3% |
| 2017 | -0.19x | $-80.41 Million | $421.04 Million | ▲ +21.5% |
| 2016 | -0.24x | $-117.02 Million | $480.75 Million | ▼ -65.1% |
| 2015 | -0.15x | $-73.08 Million | $495.63 Million | ▲ +57.9% |
| 2014 | -0.35x | $-142.01 Million | $405.29 Million | ▼ -376.9% |
| 2013 | -0.07x | $-38.53 Million | $524.43 Million | ▲ +74.5% |
| 2012 | -0.29x | $-129.76 Million | $450.77 Million | ▼ -3.4% |
| 2011 | -0.28x | $-113.74 Million | $408.74 Million | ▼ -114.4% |
| 2010 | -0.13x | $-55.87 Million | $430.56 Million | ▼ -254.5% |
| 2009 | 0.08x | $39.74 Million | $473.15 Million | ▲ +121.3% |
| 2008 | -0.39x | $-145.78 Million | $370.38 Million | ▼ -237.4% |
| 2007 | 0.29x | $146.30 Million | $510.66 Million | ▲ +267.2% |
| 2006 | -0.17x | $-92.72 Million | $541.12 Million | ▼ -16.8% |
| 2005 | -0.15x | $-78.00 Million | $531.74 Million | ▲ +47.9% |
| 2004 | -0.28x | $-78.14 Million | $277.58 Million | ▼ -67.2% |
| 2003 | -0.17x | $-76.20 Million | $452.60 Million | ▲ +10.2% |
| 2002 | -0.19x | $-74.97 Million | $399.87 Million | ▼ -46.6% |
| 2001 | -0.13x | $-50.77 Million | $396.93 Million | ▼ -25.9% |
| 2000 | -0.10x | $-35.74 Million | $351.66 Million | ▲ +7.1% |
| 1999 | -0.11x | $-15.33 Million | $140.18 Million | ▲ +89.4% |
| 1998 | -1.03x | $-19.22 Million | $18.61 Million | ▼ -570.2% |
| 1997 | 0.22x | $4.98 Million | $22.67 Million | ▲ +124.2% |
| 1996 | -0.91x | $-5.80 Million | $6.40 Million | ▲ +48.7% |
| 1995 | -1.77x | $-5.30 Million | $3.00 Million | ▲ +20.5% |
| 1994 | -2.22x | $-4.00 Million | $1.80 Million | — |